Manufacturing USA institutes are driving the expansion of emerging industries such as regenerative medicine, wearable technology, and biomanufacturing by helping overcome key barriers to scaling production. Historically, these industries have been limited to niche markets because of high entry costs and limited infrastructure. However, through technological advancements, process innovations, and cost reductions, the institutes and manufacturers are making breakthroughs that support large-scale production, positioning the U.S. to take a global leadership role in these industries. Here are three examples that illustrate these impacts.
Establishing U.S. as Global Leader in Biomanufacturing
BioMADE, the bioindustrial manufacturing institute, is making significant advancements in the U.S. biomanufacturing industry. The institute has been selected by the federal government to build the nation's first state-of-the-art biomanufacturing pilot plant at its headquarters in the Twin Cities, Minnesota. This facility will attract industry partners, support the advancement of cutting-edge technologies, and drive economic growth. It will serve as the foundation for a larger bioindustrial manufacturing campus, potentially hosting additional commercial-scale production facilities. This pilot facility is the first phase of a national bioindustrial infrastructure network. BioMADE's efforts to establish this critical infrastructure and promote collaboration between industry, academia, and government are boosting U.S. competitiveness and creating sustainable jobs in the bio-industrial sector.
Learn more about BioMADE
Bioengineering Cells, Tissues, and Organs
Regenerative manufacturing has the power to transform healthcare for chronic illness and traumatic injury and to restore form, function, and quality of life for service members, veterans, and the public. BioFabUSA is leading the development of automated platform biofabrication technologies to enable the scalable, consistent, and cost-effective production of life-saving therapies. By partnering with its member organizations, BioFabUSA has demonstrated that a scalable, modular, automated, and closed manufacturing approach can transform small-scale manual processes into consistent, cost-effective commercial products. BioFabUSA integrates the principles of good manufacturing practices with the science of regenerative medicine to pioneer regenerative manufacturing and develop the trained workforce essential for this transformative industry. The production of novel restorative and curative therapies will revolutionize healthcare for generations to come, while also strengthening U.S. health, economic, and national security.
Learn more about BioFabUSA
Positioning U.S. to Lead in Integrated Photonics
AIM Photonics is at the forefront of advancing the U.S. integrated photonics ecosystem, which enhances traditional computer chips by integrating ultra-high-speed optical signals. AIM Photonics leverages the Albany NanoTech Complex for its world-class photonic chip fabrication alongside the Institute’s Test, Assembly, and Packaging facility in Rochester, NY, to help bridge the transition from concept to manufacturing-ready prototypes for commercial and defense applications. Recognized as the world’s first, complete end-to-end silicon photonic manufacturing ecosystem, AIM Photonics provides small and medium enterprises in the U.S. with critical technology access, as well as connections with key U.S. government, industry, and academic partners. Advances in integrated photonics will help increase the U.S. share of global semiconductor manufacturing.
Learn more about AIM Photonics
Learn more about the additional Impact areas:
